News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
HANSOH PHARMACEUTICAL (01276.HK) Increases Capital by RMB285 Million in SHANGHAI RUIHONGDI
HANSOH PHARMACEUTICAL (01276.HK) announced that, together with HANSOH GROUP, SHENGDI BIOPHARMACEUTICAL FUND, and SHENZHEN YINGTAI, it will collectively increase capital by RMB750 m...
Reset
Send
The window will close in 5 seconds
HANSOH PHARMACEUTICAL (01276.HK) Increases Capital by RMB285 Million in SHANGHAI RUIHONGDI
Close
Recommend
2
Positive
3
Negative
0
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get NVDA share!

HANSOH PHARMACEUTICAL (01276.HK)  -0.250 (-0.374%)    Short selling $30.73M; Ratio 25.836%   announced that, together with HANSOH GROUP, SHENGDI BIOPHARMACEUTICAL FUND, and SHENZHEN YINGTAI, it will collectively increase capital by RMB750 million in SHANGHAI RUIHONGDI. Of this, the company will contribute RMB285 million. Upon completion, the registered capital of SHANGHAI RUIHONGDI will increase to RMB230 million, with the company's shareholding remaining at 38%. (de/d)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-04-02 16:25.)



This article was automatically translated by AI, the Chinese version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.

Auto-translated by AI
View Original Text

AASTOCKS Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.